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Editorial
Uncovering Negative Results: Introducing an Open Access 
Journal “Journal of Pharmaceutical Negative Results”
 “Once you replace negative thoughts with positive ones, you'll start 
having positive results.”
Willie Nelson
Drug discovery nowadays is a highly innovative process 
by which new drugs are discovered and/or designed. It 
is expected that in the year 2010, at least 50% of all new 
approved drugs will come from the biopharmaceutical 
sector. The discovery and validation process is mostly 
carried out by new innovative and medium-sized 
companies. But, despite advances in technology and greater 
understanding of biological systems, drug discovery is still 
a lengthy process. Specialized drug discovery companies 
need an ideal business climate, that is, political, economic 
and social conditions, to be able to cope with the 
entrepreneurial risks of drug development.
Global pharmaceutical industry is at the crossroads. On 
one side, market demand for novel and better medicines 
is getting redefined and growing due to demographic, 
economic and epidemiological trends, but at the same 
time, pharmaceutical companies are finding it difficult 
to survive since they are unable to innovate and discover 
new molecules. The pipeline of the new drug molecules is 
drying fast due to poor R and D productivity, high failure 
rate and generic competition.[1] 
Scientific research proceeds with an infinite variety in the 
availability of data, the maturity of conceptions, and the 
mix of conviction and uncertainty. Often a major discovery 
is the culmination of a process with numerous blunders, 
wrong turns, false hypotheses, missed opportunities, 
persistent hard work, lucky breaks, rational arguments, 
insightful conjectures, and accumulating knowledge 
over decades. But none of failures are being reported or 
published in the journals and other resources. This part is 
always ignored because of publishing style of most of the 
journals in pharmaceutical field.
Welcome to the Journal of  Pharmaceutical Negative Results 
(PNR). We are proud to introduce you to a new home 
for negative results focused on all aspects of Pharmacy. 
Journal of  Pharmaceutical Negative Results[2] represents the 
first open access source for research concerning negative 
results and will be a valuable resource for researchers all 
over the world, both to those who are already experts and 
also to those entering the field.
Journal of  Pharmaceutical Negative Results is a peer reviewed 
journal developed to publish original, innovative and 
novel research articles with negative results. This peer-
reviewed scientific journal publishes theoretical and 
empirical papers that report negative findings and research 
failures in pharmaceutical field. Submissions should have 
a negative focus, which means the output of research 
yielded in negative results is given more preference. All 
theoretical and methodological perspectives are welcomed. 
We also encourage the submission of short papers/
communications presenting counter-examples to usually 
accepted conjectures or to published papers.[2,3]
The main aim of the journal is to publish negative results 
so that newer generation of researchers should not waste 
their time and money repeating the same studies and finding 
the same unpublishable results. Most of the journals have 
published only the positive results and findings; however, 
they do not publish negative results. We believe that 
negative results are also a part of quality research. Thus, 
the journal focus is not only limited to negative issues 
but will also address advances in pharmaceutical research 
leading to failures. This journal will provide multilateral 
coverage of numerous applied and basic aspects of current 
pharmaceutical research.[4]
Taking into account the growing number of pharmaceutical 
journals available, one can argue whether we need 
another one like this. However, any scientist working on 
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would undoubtedly agree that there are few or no journals 
covering or boldly accepting negative results, and that 
there are no journals providing immediate open access. 
We performed an informal analysis [Figures 1 and 2] that 
shows the consistent interest of researchers to publish their 
original data in peer-reviewed pharmacy journals. A simple 
pubmed query resulted in more than 61,674 abstracts 
for significant reports and just 885 pubmed abstracts for 
insignificant results. However, to read the largest proportion 
of PubMed abstracts (over 90%) related to positive results 
published in the pharmaceutical field, it looks like research 
is always successful. Is this a right statement? Therefore, 
numerous scientists all over the world, especially those in 
the developing countries, miss the opportunity to keep 
abreast with the failures in pharmaceutical research. Since 
there are no open access journals in the pharmaceutical 
field covering negative results, the present journal fills this 
gap in the current pharmaceutical publishing.
Journal of  Pharmaceutical Negative Results aims to become 
a significant international participant in this field. The 
purpose of the journal is, therefore, to publish timely and 
high-quality articles (See author information at http://
www.pnrjournal.com/contributors.asp) concerning 
failures in techniques and negative or unexpected results 
in all areas of pharmacy. To achieve this, the Editorial 
Board of PNR journal gathers well-known experts from 
all over the world.[4] To make a decision on whether a 
manuscript fits the format of publishing in the journal, 
the Editor-in-Chief or corresponding specialists from 
the Editorial Board will immediately screen a submission 
and appropriate manuscripts will be sent for peer review 
to two independent reviewers. Based on their reports 
and scoring, a final decision will be made regarding the 
acceptance of manuscripts. Editors-in-Chief reserve the 
right to make final decisions concerning each manuscript 
submitted to the journal. At the first sight, our peer review 
system does not significantly differ from that proposed 
by other journals. However, we encourage our Editorial 
Board members as well as reviewers to be motivated critical 
advisers for improving a manuscript rather than suggesting 
rejection, which is unfortunately a common experience for 
anyone who has ever tried to publish his or her original 
negative research results.
Journal of  Pharmaceutical Negative Results is published 
by the open access publisher, Medknow Publications and 
Media Pvt. Ltd., India.[5] When submitting a manuscript, 
authors will be required to declare competing interests. In 
addition, for all the manuscripts accepted for publication, 
an article-processing charge will be levied, to cover the 
costs incurred by open access publication. We believe 
that authors' ability to publish their negative research 
should be governed only by the quality of the work and 
not financial limitations.
Considering all the advantages of this journal, we 
believe this journal to be of great benefit to the field of 
pharmacy. We invite you to work together with us to create 
this new and high-visibility open-access forum for the 
pharmaceutical sciences.
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Figure 1: Represents number of PubMed query results with the year 
limits for the MESH term “Significant, Pharmaceutical”
Figure 2: Represents number of PubMed queries resulted with the year 
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